What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Disease
Her primary scientific interests are in Breast cancer, Clinical psychology, Randomized controlled trial, Psychological intervention and Psychosocial.
Her work deals with themes such as Optimism and Anxiety, which intersect with Clinical psychology.
Randomized controlled trial is closely attributed to Stress management in her work.
As a member of one scientific family, Suzanne C. Lechner mostly works in the field of Stress management, focusing on Intervention and, on occasion, Social support, Cognitive restructuring, Quality of life and Affect.
Her Psychological intervention study combines topics from a wide range of disciplines, such as Cancer and Cognitive therapy.
Her Psychosocial study incorporates themes from Social influence, Prospective cohort study and Coping.
Her most cited work include:
- How Stress Management Improves Quality of Life after Treatment for Breast Cancer. (236 citations)
- Aging Down-Regulates the Transcription Factor E2A, Activation-Induced Cytidine Deaminase, and Ig Class Switch in Human B Cells (221 citations)
- Reduction of Cancer-Specific Thought Intrusions and Anxiety Symptoms With a Stress Management Intervention Among Women Undergoing Treatment for Breast Cancer (178 citations)
What are the main themes of her work throughout her whole career to date?
Suzanne C. Lechner mainly investigates Breast cancer, Clinical psychology, Psychosocial, Internal medicine and Stress management.
Her Breast cancer research is multidisciplinary, relying on both Intervention, Randomized controlled trial, Quality of life, Mood and Physical therapy.
Suzanne C. Lechner has researched Clinical psychology in several fields, including Psychological intervention, Prostate cancer, Quality of life and Anxiety.
Her studies deal with areas such as Cancer, Adjuvant therapy, Depression and Distress as well as Psychosocial.
Her Internal medicine study combines topics in areas such as Immunology, Endocrinology and Oncology.
Her Stress management study integrates concerns from other disciplines, such as Cognition and Affect.
She most often published in these fields:
- Breast cancer (47.37%)
- Clinical psychology (32.89%)
- Psychosocial (31.58%)
What were the highlights of her more recent work (between 2016-2021)?
- Breast cancer (47.37%)
- Internal medicine (27.63%)
- Distress (17.11%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Distress, Psychosocial and Oncology.
Her biological study spans a wide range of topics, including Physical therapy, Affect, Quality of life, Disease and Cognitive behavioral therapy.
Her Randomized controlled trial and Metastasis study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines.
Her work carried out in the field of Distress brings together such families of science as Cancer and Anxiety.
Her Anxiety research incorporates elements of Psychological intervention and Clinical psychology.
Her studies in Clinical psychology integrate themes in fields like Hospital Anxiety and Depression Scale and Depression.
Between 2016 and 2021, her most popular works were:
- Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes (22 citations)
- Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up. (18 citations)
- Differential psychological effects of cognitive-behavioral stress management among breast cancer patients with high and low initial cancer-specific distress. (13 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Suzanne C. Lechner mainly focuses on Breast cancer, Inflammation, Psychosocial, Internal medicine and Randomized controlled trial.
Her research in Breast cancer intersects with topics in Social support and Surgery.
Her Inflammation study combines topics in areas such as Metformin and Quality of life.
Her Psychosocial study combines topics from a wide range of disciplines, such as Cancer, Affect, Distress, Latent growth modeling and Stress management.
The concepts of her Internal medicine study are interwoven with issues in Physical therapy and Depression.
Her study ties her expertise on Proportional hazards model together with the subject of Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
